McCune Albright Syndrome: Clinical Trials

6 trials for McCune Albright Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1
Phase 31Completed 1
Phase 41Recruiting 1

Follow McCune Albright Syndrome: new trials by email Literature Review of McCune Albright Syndrome trials Research Report on McCune Albright Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study
Visit 1 at the center - Fibrous Dysplasia of Bone, McCune Albright Syndrome
Not applicableCompletedUniversity Hospital, Clermont-Ferrand392026-04-082026-08-21
DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)
Denosumab 120 Mg/1.7 Ml Inj, Placebo - Fibrous Dysplasia, McCune Albright Syndrome
Phase 4RecruitingNatasha Appelman-Dijkstra822023-06-132025-01-29
Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry
Fibrous Dysplasia, McCune Albright Syndrome
RecruitingTovah Burstein6002016-10-312025-08-12
A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
Pegvisomant - McCune Albright Syndrome, Polyostotic Fibrous Dysplasia
Phase 3CompletedNational Institute of Dental and Craniofacial Research (NIDCR)102001-06-012008-03-04
Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Letrozole - McCune Albright Syndrome, Polyostotic Fibrous Dysplasia
Phase 1CompletedNational Institute of Dental and Craniofacial Research (NIDCR)252000-08-032017-07-02
Effectiveness of Medical Management of Fibrous Dysplasia of Bone.
Evaluation and analysis of clinical data - Fibrous Dysplasia of Bone, McCune Albright Syndrome
CompletedHospices Civils de Lyon5281996-01-012022-06-21

Narrower conditions

Fibrous Dysplasia, Polyostotic (6)  ·  Fibrous Dysplasia of Bone (5)  ·  Acromegaly (1)  ·  Adenoma (1)  ·  Bone Diseases (1)  ·  Hyperplasia (1)  ·  Pain (1)  ·  Puberty, Precocious (1)

Broader conditions

Bone Diseases, Developmental (6)  ·  Musculoskeletal Diseases (6)  ·  Osteochondrodysplasias (6)  ·  Bone Diseases (5)  ·  Endocrine System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Bone Diseases, Endocrine (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Fibrous Dysplasia of Bone (1)  ·  Gonadal Disorders (1)  ·  Hyperpituitarism (1)  ·  Hypothalamic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Denosumab (1)  ·  Letrozole (1)  ·  pegvisomant (1)

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR) (2)  ·  Hospices Civils de Lyon (1)  ·  Natasha Appelman-Dijkstra (1)  ·  Tovah Burstein (1)  ·  University Hospital, Clermont-Ferrand (1)

Countries

United States (3)  ·  France (2)  ·  Netherlands (1)

Top investigators

Natasha Appelman-Dijsktra, MD, PhD (1)